Abstract:Objective:To synthesize novel platinum(II) complexes by the choices of the chiral centers in carrier groups and leaving groups,so as to improve the water solubility,and to find out the new platinum(II) complexes with good activities.Methods:(1R,2R)-N1-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine(LR) and(1S,2S)-N1-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine(LS) were designed and synthesized.The platinum(II) complexes were synthesized by using LR and LS as carrier ligands,and using chloride,sulfate,oxalate,malonate,1,4-butyldicarboxylate and 1,1-cyclobutyldicarboxylate anions as leaving groups.The in vitro cytotoxicity of the target compounds on human lung cancer A549,human colon cancer cell line HCT-116,human hepatoma cell line HepG2 and human breast cancer cell line MCF-7 were tested by MTT method.Results:Twelve platinum(II) complexes were synthesized and their structures were determined by elemental analysis,IR,1H-NMR and ESI-MS spectra.These platinum(II) complexes overcame the problem of poor water-solubility,and exhibited general activity to MCF-7 cell line.Conclusion:The target compounds are synthesized successfully by the choices of leaving groups and chiral centers in carrier ligands on the basis of structure of oxaliplatin.It can provide a guidance for the design of more reasonable oxaliplatin analogues containing chiral centers.

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Antitumor dinuclear platinum(II) complexes derived from a novel chiral ligand.

Synthesis, Cytotoxicity, and Apoptosis Induction Study of Antitumor Dinuclear Platinum(ii) Complexes.

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Design, Synthesis and in Vitro Cytotoxicity of Novel Dinuclear Platinum(Ii) Complexes

Synthesis and in Vitro Cytotoxicity of Platinum(Ii) Complexes with Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivatives As the Carrier Groups

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Synthesis, Characterization and Biological Evaluation of Platinum(II) Complexes with a Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivative

Synthesis and Anticancer Activity of [2-Hydroxy-1,3-diaminopropane-κ2n,n′] Platinum(ii) Complexes

Synthesis, Cytotoxicity, Induction of Apoptosis, and Interaction with DNA of Dinuclear Platinum(II) Complexes

THE SYNTHESIS AND CHARACTERIZATION OF DINUCLEAR PLATINUM COMPLEXES BRIDGED BY DIPYRIDYL SELENIDES OR SULFIDES

Study on Antitumor Platinum(Ii) Complexes of Chiral Diamines with Dicyclic Species As Steric Hindrance

Synthesis and in Vitro Cytotoxicity of Novel Hydrophilic Chiral 2-Alkoxy-1,4-butanediamine Platinum (II) Complexes.

Synthesis, crystal structures and anticancer activity of pt(II) complexes with two sterically hindered 2-methylpyridine groups as the carrier

Novel Cisplatin-Type Platinum Complexes and Their Cytotoxic Activity

Synthesis and in vitro Cytotoxicity of Platinum(Ⅱ) Complexes Chelated with Chiral N-monosubstituted 1,2-Cyclohexyldiamine Derivatives

Synthesis and Cytotoxic Evaluation of Novel Platinum(Ii) Complexes with C2-Asymmetric and C2-Symmetric Chiral Vicinal Diamines

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.